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The Way to Determine
Coenzyme Q
Coenzyme Q (CoQ, ubiquinone) is a lipophilic molecule present
in all cells, located mainly in the inner mitochondrial membrane.
It is composed of a redox active benzoquinone ring conjugated to
an isoprenoid chain. The length of the chain differs among species;
in humans, it contains predominantly 10 isoprenoid units (CoQ10).
The synthesis of this chain shares the mevalonate pathway with
cholesterol and dolichol biosynthesis (1), in which 3-hydroxy-3-
methyl-glutaryl coenzyme A (HMG-Co A) reductase is a key
enzyme and target for statins. CoQ shuttles electrons from com-
plex I and complex II, to complex III of the mitochondrial respi-
ratory chain. It also functions as a lipid-soluble antioxidant, and is
involved in multiple aspects of cellular metabolism, including
pyrimidine nucleotide biosynthesis and beta-oxidation of fatty
acids (1).
Recently, Larsen et al. (2) studied the role of simvastatin on
skeletal muscle of patients with hypercholesterolemia. This
work indicates that simvastatin compromises glucose intolerance
and decreases insulin sensitivity, and also indicates a decrease of
coenzyme Q10 (CoQ10) in human skeletal muscle. However, these
results are based on an analytical mistake because the authors have
confused the lipid antioxidant CoQ10 with the encoded protein by
the COQ10B gene. COQ10B encodes for a mitochondrial protein
that does not participate in CoQ10 biosynthesis and apparently
contributes to CoQ10 function in respiration (3).
Their paper claims the changes of CoQ10 are caused by sim-
vastatin, but the authors have analyzed the expression of Coq10b
peptide using the antibody ab41997 (Abcam, Cambridge, United
Kingdom), included in their Figure 6, that should not be confusedwith the lipid CoQ10 content. The analysis of CoQ10 is carried
out in hexane-ethanol extracts by a high-performance liquid
chromatography system with a C18 reversed-phase column and
an electrochemical detector (4). This approach has previously
demonstrated that statin drug–related myopathy is associated with
a mild decrease in muscle CoQ10 concentration (5). The overall
work of Larsen et al. (2) is not invalidated by this comment, but the
results on CoQ10 levels should be revised.*Plácido Navas, PhD
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statin-related myopathy. Arch Neurol 2005;62:1709–12.ReplyWe appreciate the comment from Dr. Navas regarding our recent
report on simvastatin’s effect on skeletal muscle (1).
We agree with Dr. Navas that the coenzyme Q–binding protein
COQ10 homolog B (COQ10B) was measured. As Dr. Navas
writes in his letter, COQ10B is essential to the function of coen-
zyme Q10 (CoQ10) in regard to mitochondrial respiration (1). In
a paper by Barros et al. (2), it is suggested that COQ10B in yeast is
binding coenzyme Q6 (CoQ6), which is necessary for CoQ6 to
transport electrons in the electron transport chain, which subse-
quently leads to the transport of electrons and production of ATP
(2). CoQ6 is present in yeast and bacteria, and is equivalent to
CoQ10 in humans (3). Previously, it has been reported that statin
treatment decreases the amount of CoQ10 in skeletal muscle (4),
and in combination with the results from our present report
observing a reduced content of COQ10B (1), this indicates that
statin treatment has a similar effect on CoQ10 and COQ10B.
COQ10B is essential for electron transport in the mitochondrial
electron transport chain, and therefore, we believe that our conclusion
in the report is valid, as Dr. Navas also writes in his letter.*Steen Larsen, MSci
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